Antitumor activities of human placenta-derived mesenchymal stem cells expressing endostatin on ovarian cancer

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Zheng, Lan ^a   Zhang, Dongmei ^b   Chen, Xiancheng ^b   Yang, Li ^b   Wei, Yuquan ^b   Zhao, Xia ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ENDOSTATIN; LIPOFECTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CACHEXIA; CELL BASED GENE THERAPY; CELL ENGINEERING; CELL HOMING; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; DRUG TARGETING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PLACENTA DERIVED MESENCHYMAL STEM CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; OVARY CANCER; SKIN APPENDAGE DISEASE; SKIN ULCER; TROPISM; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM; WEIGHT REDUCTION;

ANIMALS; CELL LINE; CELL MOVEMENT; ENDOSTATINS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PHENOTYPE; PLACENTA; PREGNANCY; TRANSDUCTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 84864219921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039119     Document Type: Article

References (34)

1. Shan W, Liu J, (2009) Epithelial ovarian cancer: focus on genetics and animal models. Cell Cycle 8: 731-735.
2. Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, et al. (2004) Focus on epithelial ovarian cancer. Cancer Cell 5: 19-24.
3. Gasparini G, (1999) The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 58: 17-38.
4. Malecki M, Kolsut P, Proczka R, (2005) Angiogenic and antiangiogenic gene therapy. Gene Ther 12: S159-169.
5. Luo X, Andres ML, Timiryasova TM, Fodor I, Slater JM, et al. (2005) Radiation-enhanced endostatin gene expression and effects of combination treatment. Technol Cancer Res Treat 4: 193-202.
6. Dkhissi F, Lu H, Soria C, Opolon P, Griscelli F, et al. (2003) Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells. Hum Gene Ther 14: 997-1008.
7. Indraccolo S, Gola E, Rosato A, Minuzzo S, Habeler W, et al. (2002) Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther 9: 867-878.
8. Li L, Huang JL, Liu QC, Wu PH, Liu RY, et al. (2004) Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery. World J Gastroenterol 10: 1867-1871.
9. Liang ZH, Wu PH, Li L, Xue G, Zeng YX, et al. (2004) Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein. Chin Med J (Engl) 117: 1809-1814.
10. Yang L, Wang L, Su XQ, Chen XC, Li D, et al. (2010) Cancer Gene Ther 17: 49-57.
11. Wang L, Yang L, Wu YK, Zhao X, Wei YQ, et al. (2009) [Intravenous delivery of cationic liposomes conjugation to recombinant adenoviral vectors containing human endostatin gene inhibits ovarian cancer growth in nude mice]. Sichuan Da Xue Xue Bao Yi Xue Ban 40: 190-194.
12. Yamanaka R, Zullo SA, Ramsey J, Onodera M, Tanaka R, et al. (2001) Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus. Cancer Gene Ther 8: 796-802.
13. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
14. Kassem M, Kristiansen M, Abdallah BM, (2004) Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 95: 209-214.
15. Miao Z, Jin J, Chen L, Zhu J, Huang W, et al. (2006) Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30: 681-687.
16. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, et al. (2004) Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22: 649-658.
17. Pereboeva L, Komarova S, Mikheeva G, Krasnykh V, Curiel DT, (2003) Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells 21: 389-404.
18. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, et al. (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318.
19. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, et al. (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62: 3603-3608.
20. Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L, (2006) Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 5: 755-766.
21. Pereboeva L, Curiel DT, (2004) Cellular vehicles for cancer gene therapy: current status and future potential. BioDrugs 18: 361-385.
22. Eichna DM, Brown KS, Breen A, Dean RB, (2008) Mucormycosis: a rare but serious infection. Clin J Oncol Nurs 12: 108-112.
23. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, et al. (2006) Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97: 744-754.
24. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
25. Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, et al. (2010) Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. American journal of obstetrics and gynecology 202: 193 e191-193 e113.
26. Liu JY, Wei YQ, Yang L, Zhao X, Tian L, et al. (2003) Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 102: 1815-1823.
27. Baksh D, Song L, Tuan RS, (2004) Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8: 301-316.
28. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, et al. (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737-1745.
29. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, et al. (2005) Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106: 419-427.
30. Wang L, Li Y, Chen X, Chen J, Gautam SC, et al. (2002) MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7: 113-117.
31. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
32. Kleinman ME, Greives MR, Churgin SS, Blechman KM, Chang EI, et al. (2007) Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 27: 2664-2670.
33. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864.
34. Rosu-Myles M, Stewart E, Trowbridge J, Ito CY, Zandstra P, et al. (2005) A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis. J Cell Sci 118: 4343-4352.